Abstract

OBJECTIVE: Preimplantational Genetic Diagnosis is a successful tool to identify specific genetic abnormalities in embryos. It has also been used to screen aneuploid embryos in women ≥38 and patients with repetitive implantation failure. In communities where it is not acceptable to discard embryos, we have previously demonstrated that Polar Body Genetic Diagnosis (PbGD) is a reasonable tool for the selection of abnormal oocytes. The aim of the present study is to determine whether PbGD improves ART results and whether it is a useful diagnostic tool to help couples take reproductive decisions.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call